Always Smile With Daewoong

home Home > About Us > Press Release > News

뉴스
No	Subject	Data
278	Daewoong Pharmaceutical has released ‘Olomax’ for both hypertension and hyperlipidemia	2019-05-03
277	Daewoong Pharmaceutical hosted a symposium titled ‘NABOTA Sparkling Night’ in Thailand	2019-05-03
276	Daewoong Pharmaceutical’s botulinum toxin about to be released in Europe with European CHMP’s recommendation for approval	2019-04-26
275	Daewoong Pharmaceutical announced the excellence of Nabota through an overseas specialist training program.	2019-04-15
274	The clinical findings of Botulinum Toxin manufactured by Daewoong have been published on international journal regarding the comparison with Botox	2019-04-12
273	Daewoong Pharmaceutical hosts a symposium for the 20th anniversary of release of Albis.	2019-04-03
272	The U.S. 3-phase clinical results of ‘Jeuveau’ is published on an SCI-level international journal	2019-03-25
271	Daewoong Pharmaceutical acquires the sales rights for Vivotif, an orally injected typhoid fever vaccine.	2019-03-19
270	Daewoong Pharmaceutical leads innovation of local business by focusing on technology transfer with Trapaco, the largest pharmaceuticals company in Vietnam.	2019-03-14
269	Daewoong Pharmaceutical ‘Nabota’ enters phase 3 clinical studies in China during the second half.	2019-03-13

1 / 2 / 3 / 4 / 5 / 6 / 7 / 8 / 9 / 10 /